Presently, Johan Erik Häggblad occupies the position of Chairman at AroCell AB and Chief Scientific Officer of Calliditas Therapeutics AB, Deputy Director at Nefecon AB (a subsidiary of Calliditas Therapeutics AB).

He is also on the board of Pharmalink Oncology AS and Deputy Director at Nefecon AB, Deputy Director at Busulipo AB and Deputy Director at Pharmalink Nordic AB.

In his past career Dr. Häggblad held the position of Principal at Karo Pharma AB, Principal at Pharmacia Corp. and Principal at Newron Sweden AB.

He received a doctorate and an undergraduate degree from the University of Stockholm.